146 related articles for article (PubMed ID: 8593019)
1. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
Blaney SM; Daniel MJ; Harker AJ; Godwin K; Balis FM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2779-82. PubMed ID: 8593019
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
Ma L; Hurwitz SJ; Shi J; Mcatee JJ; Liotta DC; McClure HM; Schinazi RF
Antimicrob Agents Chemother; 1999 Feb; 43(2):381-4. PubMed ID: 9925539
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective enzymatic biotransformation of 2'-deoxy-3'-thiacytidine (BCH 189) monitored by capillary electrophoresis.
Rogan MM; Drake C; Goodall DM; Altria KD
Anal Biochem; 1993 Feb; 208(2):343-7. PubMed ID: 8383931
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
Frick LW; St John L; Taylor LC; Painter GR; Furman PA; Liotta DC; Furfine ES; Nelson DJ
Antimicrob Agents Chemother; 1993 Nov; 37(11):2285-92. PubMed ID: 8285607
[TBL] [Abstract][Full Text] [Related]
7. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
Fox E; Murphy RF; McCully CL; Adamson PC
Cancer Chemother Pharmacol; 2001; 47(1):41-4. PubMed ID: 11221960
[TBL] [Abstract][Full Text] [Related]
8. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR
Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690
[TBL] [Abstract][Full Text] [Related]
9. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates.
Serabe BM; Murry DJ; Dauser R; Nuchtern J; Durfee J; McGuffey L; Berg S; Blaney SM
Cancer Chemother Pharmacol; 1999; 43(5):415-8. PubMed ID: 10100598
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
Martin LT; Cretton-Scott E; Schinazi RF; Zhou XJ; McClure HM; Mathe C; Gosselin G; Imbach JL; Sommadossi JP
Antimicrob Agents Chemother; 1999 Apr; 43(4):920-4. PubMed ID: 10103200
[TBL] [Abstract][Full Text] [Related]
12. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
[TBL] [Abstract][Full Text] [Related]
13. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Harker AJ; Evans GL; Hawley AE; Morris DM
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):227-32. PubMed ID: 7952073
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of lamivudine.
Johnson MA; Moore KH; Yuen GJ; Bye A; Pakes GE
Clin Pharmacokinet; 1999 Jan; 36(1):41-66. PubMed ID: 9989342
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study.
van Leeuwen R; Katlama C; Kitchen V; Boucher CA; Tubiana R; McBride M; Ingrand D; Weber J; Hill A; McDade H
J Infect Dis; 1995 May; 171(5):1166-71. PubMed ID: 7751691
[TBL] [Abstract][Full Text] [Related]
17. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
[TBL] [Abstract][Full Text] [Related]
18. High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.
Boucher CA; Cammack N; Schipper P; Schuurman R; Rouse P; Wainberg MA; Cameron JM
Antimicrob Agents Chemother; 1993 Oct; 37(10):2231-4. PubMed ID: 7504909
[TBL] [Abstract][Full Text] [Related]
19. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.
Gao Q; Gu Z; Parniak MA; Cameron J; Cammack N; Boucher C; Wainberg MA
Antimicrob Agents Chemother; 1993 Jun; 37(6):1390-2. PubMed ID: 8392313
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
